Does OLANZAPINE Cause Salivary hypersecretion? 449 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 449 reports of Salivary hypersecretion have been filed in association with OLANZAPINE (Olanzapine). This represents 0.9% of all adverse event reports for OLANZAPINE.
449
Reports of Salivary hypersecretion with OLANZAPINE
0.9%
of all OLANZAPINE reports
24
Deaths
278
Hospitalizations
How Dangerous Is Salivary hypersecretion From OLANZAPINE?
Of the 449 reports, 24 (5.3%) resulted in death, 278 (61.9%) required hospitalization, and 41 (9.1%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for OLANZAPINE.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
SERTRALINE (163)
Which OLANZAPINE Alternatives Have Lower Salivary hypersecretion Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL